3 年
手机商铺
技术资料/正文
33 人阅读发布时间:2025-01-16 16:02
The human IGFBP-7ELISA (enzyme-linked immunosorbent assay) kit is used for detection of human IGFBP-7in cell culture supernatants,human serum and plasma.THE ELISA KIT IS FOR RESEARCH USE ONLY.
Introduction
Insulin-Like Growth Factor-Binding Protein-7(IGFBP-7),also known as IGFBP-rp1,Mac25/Angiomodulin(AGM), tumor-derived adhesion factor (TAF) and prostacyclin-stimulating factor (PSF), is a secreted protein that belongs to the insulin-like growth factor (IGF) binding proteins superfamily. Human IGFBP-7 cDNA encodes 282 amino acid (aa) residue precursor protein with a putative 26 aa signal peptide. Human and mouse IGFBP7 are highly homologous and share 94% aa sequence identity.
IGFBP-7 is widely expressed in normal human tissues. It binds IGF and insulin with very low affinity and enhances the mitogenic actions of IGF and insulin. In addition to modulating the biological activities of IGF proteins, IGFBP-7 also interacts with heparan sulfate proteoglycans,type IV collagen, and specific chemokines. Some researches have shown that IGFBP-7 suppresses growth and colony
formation of prostate and breast cancer cell lines.
Principles of the Test
The kit is a solid sandwich enzyme-linked immunosorbent assay for detection of human IGFBP-7. An anti-human IGFBP-7 monoclonal antibody has been absorbed onto the wells of the microtiter strips provided. Samples including specimens or standards were pipetted into wells. The human IGFBP-7 in specimens or standards would be captured by the coated antibody and the free others were removed by washing. The human IGFBP-7 biotin-conjugated antibody were added and binds to human IGFBP-7 captured by the first antibody, which formed a sandwich. Streptavidin-HRP would be added and binds to the biotin conjugated antibody, then free Streptavidin-HRP would be removed during a wash step. After this, substrate solution would be added and catalyzed by the HRP, and a colored product is formed. The intensity of the colored product is used to calculate in proportion to the amount of human IGFBP-7 in the original specimen.
Materials provided with the kit:
|
Reagent |
96/48Test Kit |
|
HumanIGFBP-7 Antibody-Coated Wells |
12 strips/6 strips |
|
5×Standard Diluents |
60 ml/30ml |
|
HumanIGFBP-7Standard |
2/1vial(s) |
|
HumanIGFBP-7Detection Antibody |
10ml/5ml |
|
Streptavidin-HRP |
10ml/5ml |
|
Wash Buffer Concentrate 20× |
30ml/15ml |
|
TMB |
10ml/5 ml |
|
Stop Solution |
5ml/3 ml |
|
Plate Covers |
3/2 |
|
Complete Instruction Manual |
1 |
Specimen Collection
1.Collecting specimen as following:
A.The particulate of the cell culture supernatants should be removed before use.
B.Serum was obtained from clot at room temperature.
C.Please collect plasma with EDTA.
D.Assay immediately or store samples at -20℃. Avoid free-thaw cycles.
2. Antiseptic and anticoagulant should not appear in Serumsamples.
3. Any particulate should be removed from samples before use.
4. Do not use grossly hemolyzed or lipemic samples.
Note: Strongly recommend that the serum and plasma samples should be diluentsas doubling dilution before use.
Precautions for use:
1. Please storage the Kit at 2~8℃。
2. Washing buffer concentrate may have crystal in low temperature, and you can melt its in water-bath before use.
3. Please discard theremains after use of the dissolved standard.
4. Avoid contact of substrate solution with oxidizing agents and metal.
5. Usage of disposable pipette tips avoid microbial contamination or cross-contamination of reagents or specimens.
6. Do not mix or substitute reagents with those from other lots or other sources.
7. To ensure the adequate mixture of added reagents, please tap gently the plate after the wells were filled with liquid.
8. Incubation temperature should be 25~28℃.
9. Wash step was crucial for whole assay process.
10. Duplicate wells of the same sample were recommended in assay process.
11. Avoid the foam while pour the liquid into wells.
12. For serum or plasma samples ,the biotin-conjugated antibody should be incubate for at least 90 minutes.
Reagent Preparation
1.The reagents should be warmed up to room temperature before use. The remanent reagents must reseal and put into refrigeratory again as soon as possible.
2.Dilute 1ml of wash buffer Concentrate into 19ml deionized or distilled water to work.
3. If you have a 5x standard diluent, please dilute it with double steaming water or deionized water.
4. Add deionized or distilled water to the bottle according to the volume of the label and wait 15 minutes for complete dissolution. Incubation temperature should be 25~28℃。.And in turn add the half concentration diluents by standard diluents .
Wash step:
Automated microplate washer or operating by pipette: Each well should be pour into300ul wash buffer and soak 15 or 30seconds,then be aspirated, five times process were repeated. After the last wash, remove remaining wash buffer by aspirating.Invert the plate and blot it against clean paper towels.
Materials Required But Not Provided
1. pipettes and pipette tips
2. Microwell strip reader capable of reading at 450 nm (540 nm asoptional reference wave length)
3. automated microplate washer
4.Glass-distilled or deionized water
Assay procedure
1. The needed strips were putted into the frame, the remains were returned into foil pouch and resealed.
2. Blank well were recommended, which only color reagent and stop solution be added. It is suggested that each testing with gradient density of standard for standard curve.
3.Add 100ul of standard or sample.Cover with the Plate Covers provided.Incubate for 2 hours at room temperature If assay the serum sample ,you should add 50μl assay buffer with 50μl sample into the wells The IGFBP7 content of different samples is different, If there is no clear range, the dilution can start with 100 times. If the detection range is exceeded, please increase the dilution multiple before testing.
4. Five times wash process were repeated.
5. Add 100ul of detection antibody. Cover with the Plate Covers provided.Incubate for 1 hour at room temperature.
6. Five times wash process were repeated.
7. Add 100ul of Streptavidin-HRP. Cover with the Plate Covers provided. Lucifugal incubation for 20 minutes at room temperature.
8. Five times wash process were repeated.
9.Add 100ul of TMB,Lucifugal incubation for 20 minutes at room temperature.
10. Add 50ul of stop solution to each well, determine the opticaldensity of each well within 10 minutes
Calculation of Results
1. Duplicates should be within 20 percent of the mean. Average absorbance values for each set of duplicate samples were used as detection results.
2. The blank absorbance values of subtract should be deducted.
3. Drawing a best fit curve through the points of graph. Draw the standard curve by plotting assayed OD value (on the Y axis) vs. concentration (on the X axis). The sample concentration was obtained based on its OD value founding in the standard concentration curve.
4.If the values obtained are not within the expected range of the standard, Samples should be dilute and assay again.
TypicalData and Standard Curve
|
concentration (pg/ml) |
Typical data 1 |
Typical data 2 |
Average |
|
0 |
0.184 |
0.142 |
0.163 |
|
78.125 |
0.335 |
0.313 |
0.324 |
|
156.25 |
0.589 |
0.541 |
0.565 |
|
312.5 |
0.919 |
0.881 |
0.9 |
|
625 |
1.385 |
1.292 |
1.3385 |
|
1250 |
2.298 |
2.062 |
2.18 |
|
2500 |
3.168 |
3.129 |
3.1485 |
Human IGFBP-7 Standard Curve
Sensitivity, Specificity, Repeatability
Sensitivity: repeated assays were evaluated and the minimum detectable dose was 34.6pg/ml.
Specificity : No significant cross-reactivity or interference with human IGF-1, IGF-1R, IGF-2, IGFBP-1, IGFBP-2, IGFBP-3, IGFBP-4,IGFBP-5.
Repeatability: The coefficient of variation between wells or plates is less than 10 per cent.